1SCARABIN P Y, ARVEILER D, AMOUYEL P, et al. Plasma fibrinogen explains much of the difference in risk of coronary heart disease between France and Northern Ireland:the PRIME study[J]. Atherosclerosis, 2003,166 : 103- 109.
2RIDKER P M, RIFAI N, ROSE L, et al. Comparison of C-reactive protein and low density lipoprotein cholesterol levels in prediction of first cardiovascular events [J]. N Engl J Med,2002,347:1557-1565.
3PEARSON T A, MENSAH G A, ALEXANDER R W, et al. Markers of inflammation and cardiovascular disease:application to clinical and public health pracrice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation, 2003,107 : 499-511.
4USHIO S, NAMBA M, OKURA T, et al. Cloning of the eDNA for human IFN-gamma-inducing factor,expression in Escherichia colic, and studies on the biologic activities of the protein[J]. J Immunol, 1996,156:4274-4279.
5GRACIE J A,ROBERTSON S E,MCINNES I B. Interleukin-18[J]. J Leukoc Biol. 2003,73:213-224.
6TENGER C,SUNDBORGER A,JAWIEN J,et al. IL-18 accelerate atherosclerosis accompanied by elevationof IFN-gamma and CXCL16 expression independently of T cells [J]. Arterioscler Thromb Vase Biol, 2005,25:791-796.
7MALLAT Z, CORBAZ A, SCOAZEC A, et al. Interleukin-18/interleukin-18 binding protein signaling modulates atherosclerotic lesion development and stability[J]. Circ Res, 2001,89:e41 - e45.
9BLANKENBERG S, LUC G, DUCIMETIERE P, et al, Interleukin-18 and the risk of coronary heart disease in European men: the prospective epidemiological study of myocardial Infarction (PRIME) [J]. Circulation, 2003,108 : 2453 - 2459.
10MALLAT Z, CORBAZ A, SCOAZEC A, et al. Expression of interleukin-18 in human atherosclerotic plaques and relation to plaque instability[J]. Circulation, 2001,104:1598- 1603.
二级参考文献6
1[1]Whitman SC,Ravisankar P,Daugherty A.Interleukin-18 enhances atherosclerosis in apolipoprotein E (-/-) mice through release of interferon-gamma.Circ Res,2002,90(2):34-38.
3[4]Gerdes N,Sukhova GK,Libby P,et al.Expression of interleukin (IL)-18 and functional IL-18 receptor on human vascular endothelial cells,smooth muscle cells,and macrophages:implications for atherogenesis.J Exp Med,2002,195 (2):245-257.
4[5]Mallat Z,Corbaz A,Scoazec A,et al.Interleukin-18/interleukin18 binding protein signaling modulates atherosclerotic lesion development and stability.Circ Res,2001,89(7):E41-45.
5[6]Blankenberg S,Tiret L,Bickel C,et al.Interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina.Circulation,2002,106 (1):24-30.
6[7]Mallat Z,Corbaz A,Scoazec A,et al.Expression of interleukin-18in human atherosclerotic plaques and relation to plaque instability.Circulation,2001,104 (14):1598-1603.
